Navigation Links
Defined Health Announces Final Speaker Roster and Agenda for Therapeutic Insight 2008
Date:4/9/2008

FLORHAM PARK, N.J., April 9 /PRNewswire/ -- Defined Health has announced the final agenda and speaker list for its 8th annual Therapeutic Insight conference. Therapeutic Insight 2008 ("TI2008") will take place on April 28 - 30, 2008, at The Westin New York at Times Square. The following industry decision-makers and key opinion leaders will discuss relevant pharma/biotech issues and current trends in oncology, cardiovascular disease, neuropsychiatric disorders, antimicrobials, therapeutic vaccines and orphan diseases:

* Professor Ruth Arnon, The Paul Ehrlich Professor of Immunology,

Weizmann Institute of Science

* Charles Baum, MD, PhD, Vice President, Global R&D, Oncology, Pfizer

* Karen Bernstein, PhD, Chairman and Editor-in-Chief, BioCentury

* Thomas P. Blackburn, PhD, DSc, TPBioVentures LLC

* Jeffrey M. Bockman, PhD, Vice President, Defined Health

* Michael R. Bristow, MD, PhD, Founder, Chairman and Chief Science and

Medical Officer, ARCA Discovery

* Leslie J. Browne, PhD, President & CEO, Pharmacopeia Inc.

* Shannon Brownlee, Schwartz Senior Fellow, New American Foundation

* Michael D. Clayman, MD, CEO, Flexion Therapeutics

* Earl M. (Duke) Collier, Jr., JD, Executive Vice President, Genzyme

Corporation

* Albert R. Collinson, PhD, Chief Business Officer, Rib-X Pharmaceuticals

* Lode Debrabandere, PhD, Vice President & General Manager Inflammatory

Diseases, Osiris

* Mark W. Frohlich, MD, Senior VP & Chief Medical Officer, Dendreon

Corporation

* Matthew Gantz, Chief Executive Officer & Founder, Acureon Pharma

* Milton H. Grannatt, PhD, Vice President and Head, Negotiations, New

Growth Opportunities, Global Business Development & Licensing, Novartis

Pharmaceuticals Corporation

* Russell Hagan, PhD, Senior Vice President, Head of Research &

Development, BTG International

* Roger J. Hajjar, MD, Director, Cardiovascular Research Center, Mt.

Sinai School of Medicine, Arthur & Janet C. Ross Professor of Medicine,

Co-founder Celladon Corporation, Co-founder Nanocor Inc.

* Steven J. Heller, Global Marketing Leader, Oncology New Product

Development and Early Commercial Input, Johnson & Johnson Worldwide

Strategic Marketing

* Professor Jutta Heim, PhD, Chief Scientific Officer, Basilea

Pharmaceutica

* Claudia Hirawat, SVP Corporate Development, PTC Therapeutics

* Ginger S. Johnson, PhD, Vice President, Defined Health

* Matthew W. Kalnik, PhD, VP, Business Development & Project Management,

Nabi Biopharmaceuticals

* Jeremy Levin, PhD, Senior Vice President, External Science, Technology

and Licensing, Bristol-Myers Squibb

* Christopher Lipinski, PhD, Scientific Advisor, Melior Discovery

* Joseph S. McCracken, DVM, Vice President, Business & Commercial

Development, Genentech

* David P. Meeker, MD, President, LSD Therapeutics, Genzyme

* Eszter Nagy, MD, PhD, Vice President, Pre-clinical R&D, Intercell

* Steve J. Offord, PhD, Vice President CNS New Products Marketing, Market

Access and Business Development, sanofi-aventis

* Carlos Plata-Salaman, DSc, MD, Head, Global External Research &

Development, Eli Lilly & Co.

* Edward C. Saltzman, President, Defined Health

* Deborah Schrag, MD, Associate Professor of Medicine, Dana-Farber Cancer

Institute

* Mark J. Simon, President, Williver Group LLC

* Greg Wiederrecht, PhD, Vice President & Head, External Scientific

Affairs, Merck & Co.

* Daphne Zohar, Founder & Managing Partner, PureTech Ventures

The final agenda, list of speakers and registration information along with content and attendee statistics from prior Therapeutic Insight conferences is available on the conference website, http://www.therapeuticinsight.com.

Shannon Brownlee, Schwartz Senior Fellow at the New America Foundation, will present a keynote address at TI2008 entitled, "Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer." Her book of the same title was named the best economics book of 2007 by the New York Times. Ms. Brownlee's speaking fee will be donated to charity.

The 2+ day conference will include two networking events, with additional opportunities for interaction throughout the event. The conference will begin on Tuesday morning, April 29, with a plenary presentation by Ed Saltzman, President of Defined Health, entitled: "Surviving, Sustaining and Succeeding in the Pursuit of Innovation."

Therapeutic Insight 2008 is presented by Defined Health and Communitech Market Intelligence, with a sponsorship from JNK Securities. To register, or for more information, please visit http://www.therapeuticinsight.com, or contact Communitech: (914) 245-7764, http://www.cmius.com, or Defined Health: (973) 292-5001, http://www.definedhealth.com.

Contact:

Ginny E. Llobell

Vice President

Defined Health

973-292-5001 X 235


'/>"/>
SOURCE Defined Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sensitivity of brain center for sound space defined
2. Pathway to cell death redefined in landmark study
3. Pathway to cell death redefined in landmark study
4. John Hancock Launches Defined Benefit Program
5. New upper limit defined for normal ALT in adolescent males
6. Shannon Brownlee, Author of Overtreated, to Keynote at Defined Healths 8th Annual Therapeutic Insight Conference
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. UCLA researchers identify markers that may predict diabetes in still-healthy people
9. Air pollution linked to cardiovascular risk indices in healthy young adults
10. More proof needed of safety and quality of electronic personal health records
11. Health care incentive model offers collaborative approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, ...
(Date:2/12/2016)... Middletown, PA (PRWEB) , ... February 12, 2016 , ... ... year’s event will be held in Anaheim, CA at the Anaheim Convention Center. Almost ... they can see new therapy products in action, learn more about their chosen field ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... firm announced that nominations have closed for the ISE Southeast Awards 2016. Finalists ... be announced at the ISE® Southeast Executive Forum and Awards Gala on March ...
(Date:2/12/2016)... ... 12, 2016 , ... Every winter, someone is killed, injured or loses a ... Burn Center, part of the Allegheny Health Network, has partnered with Etna Volunteer ... Heaters Need Space” campaign. , “Space Heaters Need Space” aims to bring ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
(Date:2/12/2016)... February 12, 2016 ... titled Chronic Inflammation Global Clinical Trials Review, H2, ... the global clinical trials landscape along with top ... Region, Country (G7 & E7), Trial Status, Trial ... reviews top companies involved and enlists all trials ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
Breaking Medicine Technology: